Barclays raised the firm’s price target on UnitedHealth to $560 from $534 and keeps an Overweight rating on the shares post the Q1 report. The analyst is positive on the stock following a “solid” earnings report, “encouraging” pricing and reserving, a “de-risked” forward outlook, and a favorable setup into 2025 Medicare Advantage bids.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UNH Earnings: UnitedHealth Jumps on Resilient Q1 Performance
- Options Volatility and Implied Earnings Moves Today, April 16, 2024
- Notable companies reporting before tomorrow’s open
- UnitedHealth management to meet with Stephens
- Centene rises, Molina slides following Floridaâs managed Medicaid awards
